Abstract:Abstract BackgroundDepression is one of the most prevalent mental illnesses in the world today, the onset of depression is usually accompanied by neuroinflammation and neurogenic damage. Recently, G protein coupled receptor 55 (GPR55) has been associated with mood regulation as a third kind of cannabinoid receptor, and the activation of GPR55 was demonstrated recently to have a neuroprotective effect on hippocampal neurogenesis against inflammatory insult. However, its role in regulating depression and anxiety remains poorly understood.Methods10-day chronic social defeat stress (CSDS) was utilized as an animal model of depression to explore the potential antidepressant effect of GPR55 agonist and electroacupuncture (EA), a common therapy for depression in China. Several behavioral tests i.e. forced swimming test, open field test and elevated plus maze were performed to evaluate the depression- and anxiety-like behaviors in mice. Expression of GPR55, hippocampal neuroinflammation, and neurogenesis were detected using immunohistochemistry, western blot and RT-PCR. Then, the effect of a GPR55 agonist, O-1602 on depression- and anxiety-like behaviors as well as hippocampal neuroinflammation and neurogenesis was examined. Furthermore, the potential antidepressant effect of 3-week EA treatment was also evaluated in another independent experiment. In the experiment, the behaviors and hippocampal neuroinflammation and neurogenesis were also subsequently examined.ResultsAfter CSDS, the protein level of GPR55 was decreased only in susceptible mice but the mRNA expression was not significantly different in all CSDS mice. Additionally, depression- and anxiety-like behaviors are accompanied by neuroinflammation and reduced neurogenesis in the hippocampus. And the activation of GPR55 during the process of CSDS prevented the development of depression- and anxiety- like behaviors, as well as hippocampal neuroinflammation and neurogenetic damage. Similarly, EA alleviated the depression- and anxiety-like behaviors, hippocampal neuroinflammation, and neurogenetic damage as well as decreased protein level of GPR55 in hippocampus induced by CSDS.ConclusionsOur research demonstrated that activation of hippocampal GPR55 could rescue depression and anxiety phenotypes, reduce hippocampal neuroinflammation, and enhance hippocampal neurogenesis. Moreover, GPR55 might be involved in the beneficial effect of EA on depression.

Effects of Hippocampal PGC-1α on Depression-Like Behaviors and Number of Astrocytes in Hippocampal Subregions in Mice

PGC-1α in the hippocampus mediates depressive-like and stress-coping behaviours and regulates excitatory synapses in the dentate gyrus in mice

Defects of Parvalbumin-Positive Interneurons in the Ventral Dentate Gyrus Region Are Implicated Depression-Like Behavior in Mice.

Microglial Glutaminase 1 Deficiency Mitigates Neuroinflammation Associated Depression.

Continuous GSK-3β overexpression in the hippocampal dentate gyrus induces prodepressant-like effects and increases sensitivity to chronic mild stress in mice.

Microglia Loss and Astrocyte Activation Cause Dynamic Changes in Hippocampal [18F]DPA-714 Uptake in Mouse Models of Depression

Reduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1

Deficiency of Glycosylated-Α-dystroglycan in Ventral Hippocampus Bridges the De-Stabilization of Gamma-Aminobutyric Acid Type A Receptors with the Depressive-Like Behaviors of Male Mice

The Protective Effects of GPR55 Against Hippocampal Neuroinflammation and Neurogenic Damage in CSDS Mice

Deficiency of Glycosylated α-Dystroglycan in Ventral Hippocampus Bridges the Destabilization of Gamma-Aminobutyric Acid Type A Receptors With the Depressive-like Behaviors of Male Mice

Ginsenosides modulate hypothalamic-pituitary-adrenal function by inhibiting FKBP51 on glucocorticoid receptor to ameliorate depression in mice exposed to chronic unpredictable mild stress

Ginsenoside Rb1 Induces a Pro-Neurogenic Microglial Phenotype Via PPARγ Activation in Male Mice Exposed to Chronic Mild Stress

A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment

Microglial PCGF1 alleviates neuroinflammation associated depressive behavior in adolescent mice

Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer's Disease

Mice Lacking the Transcriptional Coactivator PGC-1α Exhibit Hyperactivity

PGAM5 knockout causes depressive-like behaviors in mice via ATP deficiency in the prefrontal cortex

Ginsenoside Rg1 ameliorates depressive-like behavior by inhibiting NLRP3 inflammasome activation in mice exposed to chronic stress

PDGF‐BB‐Dependent Neurogenesis Buffers Depressive‐Like Behaviors by Inhibition of GABAergic Projection from Medial Septum to Dentate Gyrus

Ginsenoside Rb1 protects hippocampal neurons in depressed rats based on mitophagy-regulated astrocytic pyroptosis

Role of PGC-1α Mediated Synaptic Plasticity, Mitochondrial Function, and Neuroinflammation in the Antidepressant Effect of Zi-Shui-Qing-Gan-Yin